MedTrace Logo

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

NCT01114204 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 605

Last updated 2022-04-21

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA).

Conditions

Interventions

DRUG

Ferumoxytol

IV Ferumoxytol

DRUG

Iron Sucrose

IV Iron Sucrose

Sponsors & Collaborators

  • AMAG Pharmaceuticals, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-10
Primary Completion
2011-11-09
Completion
2012-06-25

Countries

  • Australia
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • South Africa
  • South Korea
  • Spain
  • Ukraine
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01114204 on ClinicalTrials.gov